Market Tracker

01/20 5:16pm ET

Repros Therapeutics Inc (NASDAQ:RPRX)

1.41
Delayed Data
As of Jan 20
 +0.05 / +3.68%
Today’s Change
0.80
Today|||52-Week Range
3.48
+6.82%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close1.36
Today’s open1.39
Day’s range1.32 - 1.43
Volume93,052
Average volume (3 months)194,918
Market cap$35.8M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+13.67%
Earnings growth (this year)+40.42%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.85

Competitors

 Today’s
change
Today’s
% change
DMPIDelMar Pharmaceutica...-0.10-2.79%
THLDThreshold Pharmaceut...-0.03-5.02%
IMMYImprimis Pharmaceuti...+0.09+3.37%
TPIVTapImmune Inc-0.02-0.45%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$29.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts